Emverm
Pricing Report NDC 64896-669-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The current wholesale acquisition cost for Emverm (NDC 64896-669-30) is $711.89357 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a provided by Amneal Pharmaceuticals Llc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$711.89357
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
1 EA
Estimated Package Price
$711.89
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
64896-669-30
Description
1 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2017, the NADAC wholesale price for (NDC ) has moved within a range of $353.05000 to $714.77121 per EA. Over this 8 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$353.0500 - $714.7712
Market Volatility
102.46% Variance
Latest Trend
0.01%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $711.89357 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
May 20, 2026 $711.93136 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Apr 22, 2026 $711.42932 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Mar 18, 2026 $711.43070 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Dec 17, 2025 $712.20646 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Dec 17, 2025 $712.20646 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Nov 19, 2025 $712.33262 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Oct 22, 2025 $710.22121 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Sep 17, 2025 $710.62571 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 20, 2025 $710.56409 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jul 23, 2025 $710.22800 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jun 18, 2025 $710.74294 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jan 22, 2025 $650.01305 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jan 20, 2025 $714.77121 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 20, 2025 $714.77121 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 20, 2025 $714.77121 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2024 $650.38327 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Nov 20, 2024 $650.22979 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Oct 23, 2024 $648.42109 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Sep 18, 2024 $651.23548 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 21, 2024 $651.80500 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jul 17, 2024 $651.60097 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jun 19, 2024 $651.97955 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
May 22, 2024 $653.40929 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2024 $648.39022 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2024 $648.39022 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2024 $648.39022 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 20, 2023 $589.98200 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Dec 20, 2023 $589.98200 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2023 $591.86562 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2023 $591.86562 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2023 $591.86562 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2022 $538.54925 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2022 $538.54925 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 01, 2022 $538.54925 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 22, 2021 $490.03125 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Dec 22, 2021 $490.03125 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Feb 15, 2021 $488.96494 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 15, 2021 $488.96494 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 15, 2021 $488.96494 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Nov 18, 2020 $444.91400 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Nov 18, 2020 $444.91400 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Nov 18, 2020 $444.91400 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Jun 17, 2020 $442.52000 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Jun 17, 2020 $442.52000 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jun 17, 2020 $442.52000 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Feb 25, 2020 $447.72883 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 25, 2020 $447.72883 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 25, 2020 $447.72883 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $407.39286 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $407.39286 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 23, 2019 $406.46759 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 23, 2019 $406.46759 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 23, 2019 $406.46759 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Jan 04, 2019 $405.08917 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Aug 01, 2018 $368.59797 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Aug 01, 2018 $368.59797 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Aug 01, 2018 $368.59797 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
May 01, 2018 $388.00195 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
May 01, 2018 $388.00195 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
May 01, 2018 $388.00195 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Feb 21, 2018 $353.05000 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Feb 21, 2018 $353.05000 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 13, 2017 $353.55833 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026